Sitting on a Pile of Cash 3.0? Fixing Brain System Disorders

By Paul Ebeling on July 2, 2020   2020, Investments, Paul Ebeling, Todays Trade Ideas  

#brain #synaptic #plasticity #NMDR, #AptinyX #Allergan #rewire #treatment $APTX Aptinyx Inc. (NASDAQ:APTX) now has a Strong Buy rating with an 20+ price target long term, we note that the company has opened a path to NMDAR modulation that can restore synaptic plasticity and rewire the brain. APTX broke out on 6 May and confirmed on […]